Search

Your search keyword '"Warszawski, J."' showing total 398 results

Search Constraints

Start Over You searched for: Author "Warszawski, J." Remove constraint Author: "Warszawski, J."
398 results on '"Warszawski, J."'

Search Results

6. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

9. The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/μL in the Post—Combination Antiretroviral Therapy Era

10. Children living with HIV in Europe: do migrants have worse treatment outcomes?

14. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

15. Higher rates of triple‐class virological failure in perinatally HIV‐infected teenagers compared with heterosexually infected young adults in Europe

16. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

20. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies

22. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

23. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis

24. Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE

26. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL

31. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

32. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?

33. 1-2 - Evolution de la relation entre le sexe et la présence de symptômes post-COVID selon l’âge

34. Outcomes of second-line antiretroviral therapy among children living with HIV : a global cohort analysis

38. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

39. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

42. Paediatr Int Child Health

43. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

44. CD4 recovery following antiretroviral treatment interruptions in children and adolescents with HIV infection in Europe and Thailand

45. Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV : an international cohort collaboration [plus Supplementary appendix]

46. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand

49. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

50. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients

Catalog

Books, media, physical & digital resources